TAG ARCHIVES FOR industry

1
Aug2014

As summer swings into full gear, be sure to take a break from the heat to delve into the research ethics news making headlines this month. 
 
The Era of Big Data and its Implication for Big Pharma: The integration of technology into health care has resulted in an abundance of data about our health. In this piece for the Health Affairs Blog, Marc Berger et al. discuss how “big [...] Read more

23
Jul2013

by Joan Rachlin, JD, MPH, Executive Director

Among the many topics that will be presented and discussed at the 2013 Advancing Ethical Research Conference is the ubiquitous issue of data transparency. Some of the most hotly debated questions making the research ethics rounds include who should interpret, distribute, review, and receive data, and with good reason. From WikiLeaks to National Security Agency (NSA) whistleblowers, and all other manner and [...] Read more

8
Dec2012

by Julie Fine, BS, legal specialist, Legal Division, Worldwide Research and Development, Pfizer Inc. (Please note: The views presented here are my own and do not reflect the positions or policies of Pfizer, Inc.)

During lunch on Tuesday, I took advantage of the opportunity to join other conference attendees for an intimate and informal question and answer session with Keynote Speaker, Read more